FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Koshi Mimori

Research Profile

Chemicals & Drugs

Physiology

Disorders

Procedures

Anatomy

Devices

Oligonucleotide Array Sequence Analysis

Concepts & Ideas

Co-author Network

Publications

TOP 3
Yusuke Takahashi; Yuki Takano; Ryutaro Uchi; Hiroki Ueo; Hirofumi Yamamoto; Masaki Mori; Genta Sawada; Tomoya Sudo; Keishi Sugimachi; Sayuri Akiyoshi; Yuichiro Doki; Hidetoshi Eguchi; Masahisa Ishibashi; Takeshi Iwaya; Junji Kurashige; Tae Matsumura; Koshi Mimori
Tumor-derived Tenascin-C Promotes the Epithelial-Mesenchymal Transition in Colorectal Cancer Cells.
Takehiko Yokobori; Graham F Barnard; Takeo Fukagawa; Hisae Iinuma; Seiya Imoto; Hideshi Ishii; Masaaki Iwatsuki; Takeshi Iwaya; Ryunosuke Kogo; Hiroyuki Kuwano; Koshi Mimori; Satoru Miyano; Hayao Nakanishi; Naohiro Nishida; Masahisa Ohkuma; Daisuke Ota; Klaus Pantel; Shin Sasaki; Tetsuya Sato; Kohei Shibata; Teppei Shimamura; Tomoya Sudo; Keishi Sugimachi; Fumiaki Tanaka; Hiroyuki Toh; Toshiaki Watanabe; Seiichiro Yamamoto; Masaki Mori
Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis.
Yasushi Takatsuno; Jun-Ichi Tanaka; Hiroyuki Toh; Shinkan Tokudome; Masahiko Watanabe; Kazutaka Yamada; Rui Yamaguchi; Ken Yamamoto; Hisae Iinuma; Seiya Imoto; Hiroshi Inoue; Hideshi Ishii; Shinya Ishimaru; Shuhei Kawano; Shin-Ei Kudo; Masato Kusunoki; Koshi Mimori; Satoru Miyano; Hidetaka Mochizuki; Yoshihiro Moriya; Atsushi Niida; Tetsuya Sato; Yasuhiro Shimada; Kenichi Sugihara; Sadao Suzuki; Masaki Mori
The rs6983267 SNP is associated with MYC transcription efficiency, which promotes progression and worsens prognosis of colorectal cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Koshi Mimori (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Yusuke Takahashi; Yuki Takano; Ryutaro Uchi; Hiroki Ueo; Hirofumi Yamamoto; Masaki Mori; Genta Sawada; Tomoya Sudo; Keishi Sugimachi; Sayuri Akiyoshi; Yuichiro Doki; Hidetoshi Eguchi; Masahisa Ishibashi; Takeshi Iwaya; Junji Kurashige; Tae Matsumura; Koshi Mimori
Tumor-derived Tenascin-C Promotes the Epithelial-Mesenchymal Transition in Colorectal Cancer Cells.
Anticancer research 2013;33(5):1927-34.
2013: Takehiko Yokobori; Graham F Barnard; Takeo Fukagawa; Hisae Iinuma; Seiya Imoto; Hideshi Ishii; Masaaki Iwatsuki; Takeshi Iwaya; Ryunosuke Kogo; Hiroyuki Kuwano; Koshi Mimori; Satoru Miyano; Hayao Nakanishi; Naohiro Nishida; Masahisa Ohkuma; Daisuke Ota; Klaus Pantel; Shin Sasaki; Tetsuya Sato; Kohei Shibata; Teppei Shimamura; Tomoya Sudo; Keishi Sugimachi; Fumiaki Tanaka; Hiroyuki Toh; Toshiaki Watanabe; Seiichiro Yamamoto; Masaki Mori
Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis.
Cancer research 2013;73(7):2059-69.
2013: Yasushi Takatsuno; Jun-Ichi Tanaka; Hiroyuki Toh; Shinkan Tokudome; Masahiko Watanabe; Kazutaka Yamada; Rui Yamaguchi; Ken Yamamoto; Hisae Iinuma; Seiya Imoto; Hiroshi Inoue; Hideshi Ishii; Shinya Ishimaru; Shuhei Kawano; Shin-Ei Kudo; Masato Kusunoki; Koshi Mimori; Satoru Miyano; Hidetaka Mochizuki; Yoshihiro Moriya; Atsushi Niida; Tetsuya Sato; Yasuhiro Shimada; Kenichi Sugihara; Sadao Suzuki; Masaki Mori
The rs6983267 SNP is associated with MYC transcription efficiency, which promotes progression and worsens prognosis of colorectal cancer.
Annals of surgical oncology 2013;20(4):1395-402.
2013: Masahisa Ishibashi; Takeshi Iwaya; Ryunosuke Kogo; Junji Kurashige; Koshi Mimori; Shin Sasaki; Genta Sawada; Kohei Shibata; Tomoya Sudo; Keishi Sugimachi; Yusuke Takahashi; Go Wakabayashi; Sayuri Akiyoshi; Masaki Mori
Clinical significance of the expression of long non-coding RNA HOTAIR in primary hepatocellular carcinoma.
Oncology reports 2013;29(3):946-50.
2013: Hirofumi Yamamoto; Yuichiro Doki; Mutsumi Fukunaga; Naotsugu Haraguchi; Kimimasa Ikeda; Masakazu Ikenaga; Takeshi Kato; Koshi Mimori; Tsunekazu Mizushima; Kohei Murata; Junichi Nishimura; Tadashi Ohnishi; Masayuki Ohue; Shu Okamura; Ichiro Takemasa; Mitsuyoshi Tei; Mamoru Uemura; Yoshio Uemura; Masaki Mori
Ephrin-A1 mRNA is associated with poor prognosis of colorectal cancer.
International journal of oncology 2013;42(2):549-55.
2013: Sayuri Akiyoshi; Koshi Mimori; Kohei Shibata; Tomoya Sudo; Fumiaki Tanaka; Masaki Mori
Laparoscopic surgery minimizes the surgical manipulation of isolated tumor cells leading to decreased metastasis compared to open surgery for colorectal cancer.
Surgery today 2013;43(1):20-5.
2012: Junichi Nishimura; Mitsugu Sekimoto; Kohei Shibata; Ichiro Takemasa; Fumiaki Tanaka; Hirofumi Yamamoto; Yuichiro Doki; Rio Handa; Masataka Ikeda; Hideshi Ishii; Koshi Mimori; Tsunekazu Mizushima; Masaki Mori
microRNA-181a is associated with poor prognosis of colorectal cancer.
Oncology reports 2012;28(6):2221-6.
2012: Takeshi Iwaya; Ryunosuke Kogo; Masahisa Ishibashi; Masaki Mori; Naohiro Nishida; Genta Sawada; Kohei Shibata; Tomoya Sudo; Yusuke Takahashi; Fumiaki Tanaka; Go Wakabayashi; Takehiko Yokobori; Koshi Mimori
Downregulation of miR-144 is associated with colorectal cancer progression via activation of mTOR signaling pathway.
Carcinogenesis 2012;33(12):2391-7.
2012: Shinya Ishimaru; Shuichi Kawano; Shin-ei Kudo; Masato Kusunoki; Toyoki Maeda; Koshi Mimori; Satoru Miyano; Hidetaka Mochizuki; Yoshihiro Moriya; Tetsuya Sato; Yasuhiro Shimada; Ken-ichi Sugihara; Sadao Suzuki; Jun-ichi Tanaka; Hiroyuki Toh; Shinkan Tokudome; Masahiko Watanabe; Kazutaka Yamada; Rui Yamaguchi; Ken Yamamoto; Graham F Barnard; Kazuo Hase; Hisae Iinuma; Seiya Imoto; Hiroshi Inoue; Hideshi Ishii; Masaki Mori
Increased risk for CRC in diabetic patients with the nonrisk allele of SNPs at 8q24.
Annals of surgical oncology 2012;19(9):2853-8.
2012: Naohiro Nishida; Kohei Shibata; Tomoya Sudo; Fumiaki Tanaka; Hirofumi Yamamoto; Shinya Yamashita; Yuichiro Doki; Hideshi Ishii; Koshi Mimori; Masaki Mori
MicroRNA-10b is a prognostic indicator in colorectal cancer and confers resistance to the chemotherapeutic agent 5-fluorouracil in colorectal cancer cells.
Annals of surgical oncology 2012;19(9):3065-71.
2012: Takehiko Yokobori; Hideshi Ishii; Masaaki Iwatsuki; Takeshi Iwaya; Hiroyuki Kuwano; Koshi Mimori; Keiichi I Nakayama; Ichiro Onoyama; Tetsuya Sato; Tomoya Sudo; Fumiaki Tanaka; Yoichi Tanaka; Hiroyuki Toh; Masaki Mori
Copy number loss of FBXW7 is related to gene expression and poor prognosis in esophageal squamous cell carcinoma.
International journal of oncology 2012;41(1):253-9.
2012: Ho Min Kim; Koshi Mimori; Yuichiro Doki; Hidetoshi Eguchi; Naotsugu Haraguchi; Hideshi Ishii; Hiroaki Nagano; Masahisa Ohkuma; Miho Okano; Mitsugu Sekimoto; Hirofumi Yamamoto; Masaki Mori
Increased CD13 expression reduces reactive oxygen species, promoting survival of liver cancer stem cells via an epithelial-mesenchymal transition-like phenomenon.
Annals of surgical oncology 2012;19 Suppl 3():S539-48.
2012: Yoshimasa Kosaka; Koshi Mimori; Takeshi Sano; Mitsuru Sasako; Masahiko Watanabe; Tsuyoshi Etoh; Takeo Fukagawa; Kenji Ishikawa; Hitoshi Katai; Masaki Mori
Clinical significance of molecular detection of matrix metalloproteinase-1 in bone marrow and peripheral blood in patients with gastric cancer.
Annals of surgical oncology 2012;19 Suppl 3():S430-7.
2012: Yusuke Takahashi; Jun-Ichi Tanaka; Masahiko Watanabe; Kazutaka Yamada; Ken Yamamoto; Kazuo Hase; Shin-Ei Kudo; Masato Kusunoki; Koshi Mimori; Hidetaka Mochizuki; Yoshihiro Moriya; Yasuhiro Shimada; Ken-Ichi Sugihara; Masaki Mori
Genomic copy number of a carcinogenic single nucleotide polymorphism at 8q24 in non-risk allele colorectal cancer associated with insulin growth factor 2 receptor expression.
Journal of gastroenterology and hepatology 2012;27 Suppl 3():95-9.
2012: Masahisa Ohkuma; Miho Shimomura; Fumiaki Tanaka; Katsuhiko Yanaga; Naotsugu Haraguchi; Hajime Hirose; Hideshi Ishii; Ho Min Kim; Koshi Mimori; Masaki Mori
Absence of CD71 transferrin receptor characterizes human gastric adenosquamous carcinoma stem cells.
Annals of surgical oncology 2012;19(4):1357-64.
2012: Yusuke Takahashi; Koshi Mimori; Masaki Mori
[Significance of genome-wide association study in cancer].
Nihon Geka Gakkai zasshi 2012;113(2):210-4.
2012: Koshi Mimori; Kohei Shibata; Fumiaki Tanaka; Masaki Mori
Review: Single nucleotide polymorphisms associated with the oncogenesis of colorectal cancer.
Surgery today 2012;42(3):215-9.
2012: Shinya Yamashita; Yuichiro Doki; Naotsugu Haraguchi; Hideshi Ishii; Koshi Mimori; Naohiro Nishida; Mitsugu Sekimoto; Kohei Shibata; Hidekazu Takahashi; Fumiaki Tanaka; Hirofumi Yamamoto; Masaki Mori
MicroRNA-372 is associated with poor prognosis in colorectal cancer.
Oncology 2012;82(4):205-12.
2011: Makoto Nagahara; Tsuyoshi Nakagawa; Naohiro Nishida; Takanobu Sato; Kenichi Sugihara; Fumiaki Tanaka; Dave S B Hoon; Shinya Ishimaru; Masaaki Iwatsuki; Koshi Mimori; Masaki Mori
Kinesin 18A expression: clinical relevance to colorectal cancer progression.
International journal of cancer. Journal international du cancer 2011;129(11):2543-52.
2011: Ryunosuke Kogo; Shizuo Komune; Koshi Mimori; Satoru Miyano; Kohei Shibata; Teppei Shimamura; Tomoya Sudo; Akira Suzuki; Fumiaki Tanaka; Seiya Imoto; Kohichi Kawahara; Masaki Mori
Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers.
Cancer research 2011;71(20):6320-6.
2011: Tomoya Sudo; Fumiaki Tanaka; Naohiro Nishida; Kohei Shibata; Kazuo Shirouzu; Hiromasa Fujita; Takeshi Iwaya; Ryunosuke Kogo; Koshi Mimori; Masaki Mori
Histone deacetylase 1 expression in gastric cancer.
Oncology reports 2011;26(4):777-82.
2011: Hajime Hirose; Masataka Ikeda; Hideshi Ishii; Koshi Mimori; Tsunekazu Mizushima; Mitsugu Sekimoto; Ichiro Takemasa; Fumiaki Tanaka; Hirofumi Yamamoto; Yuichiro Doki; Masaki Mori
The significance of PITX2 overexpression in human colorectal cancer.
Annals of surgical oncology 2011;18(10):3005-12.
2011: Fumiaki Tanaka; Hiroshi Inoue; Yoshiaki Kita; Shinji Matsuzaki; Koshi Mimori; Masaki Mori
Clinicopathological and biological significance of CDC28 protein kinase regulatory subunit 2 overexpression in human gastric cancer.
International journal of oncology 2011;39(2):361-72.
2011: Ryunosuke Kogo; Shizuo Komune; Koshi Mimori; Fumiaki Tanaka; Masaki Mori
Clinical significance of miR-146a in gastric cancer cases.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(13):4277-84.
2011: Ryunosuke Kogo; Koshi Mimori; Fumiaki Tanaka; Shizuo Komune; Masaki Mori
FBXO31 determines poor prognosis in esophageal squamous cell carcinoma.
International journal of oncology 2011;39(1):155-9.
2011: Norikatsu Miyoshi; Hideshi Ishii; Hiroaki Nagano; Naotsugu Haraguchi; Dyah Laksmi Dewi; Yoshihiro Kano; Shinpei Nishikawa; Masahiro Tanemura; Koshi Mimori; Fumiaki Tanaka; Toshiyuki Saito; Junichi Nishimura; Ichiro Takemasa; Tsunekazu Mizushima; Masataka Ikeda; Hirofumi Yamamoto; Mitsugu Sekimoto; Yuichiro Doki; Masaki Mori
Reprogramming of mouse and human cells to pluripotency using mature microRNAs.
Cell stem cell 2011;8(6):633-8.
2011: Naohiro Nishida; Takehiko Yokobori; Koshi Mimori; Tomoya Sudo; Fumiaki Tanaka; Kohei Shibata; Hideshi Ishii; Yuichiro Doki; Hiroyuki Kuwano; Masaki Mori
MicroRNA miR-125b is a prognostic marker in human colorectal cancer.
International journal of oncology 2011;38(5):1437-43.
2011: Naohiro Nishida; Koshi Mimori; Muller Fabbri; Takehiko Yokobori; Tomoya Sudo; Fumiaki Tanaka; Kohei Shibata; Hideshi Ishii; Yuichiro Doki; Masaki Mori
MicroRNA-125a-5p is an independent prognostic factor in gastric cancer and inhibits the proliferation of human gastric cancer cells in combination with trastuzumab.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(9):2725-33.
2011: Daisuke Ota; Koshi Mimori; Takehiko Yokobori; Masaaki Iwatsuki; Akemi Kataoka; Norikazu Masuda; Hideshi Ishii; Shinji Ohno; Masaki Mori
Identification of recurrence-related microRNAs in the bone marrow of breast cancer patients.
International journal of oncology 2011;38(4):955-62.
2011: Hidekazu Takahashi; Hideshi Ishii; Naohiro Nishida; Ichiro Takemasa; Tsunekazu Mizushima; Masataka Ikeda; Takehiko Yokobori; Koshi Mimori; Hirofumi Yamamoto; Mitsugu Sekimoto; Yuichiro Doki; Masaki Mori
Significance of Lgr5(+ve) cancer stem cells in the colon and rectum.
Annals of surgical oncology 2011;18(4):1166-74.
2011: Mamoru Uemura; Hirofumi Yamamoto; Ichiro Takemasa; Koshi Mimori; Tsunekazu Mizushima; Masataka Ikeda; Mitsugu Sekimoto; Yuichiro Doki; Masaki Mori
Hypoxia-inducible adrenomedullin in colorectal cancer.
Anticancer research 2011;31(2):507-14.
2011: Megumi Kawamoto; Fumiaki Tanaka; Koshi Mimori; Hiroshi Inoue; Yukio Kamohara; Masaki Mori
Identification of HLA-A*0201/-A*2402-restricted CTL epitope-peptides derived from a novel cancer/testis antigen, MCAK, and induction of a specific antitumor immune response.
Oncology reports 2011;25(2):469-76.
2011: Naohiro Nishida; Koshi Mimori; Takehiko Yokobori; Tomoya Sudo; Fumiaki Tanaka; Kohei Shibata; Hideshi Ishii; Yuichiro Doki; Masaki Mori
FOXC2 is a novel prognostic factor in human esophageal squamous cell carcinoma.
Annals of surgical oncology 2011;18(2):535-42.
2011: Yoshiaki Kita; Koshi Mimori; Masaaki Iwatsuki; Takehiko Yokobori; Keisuke Ieta; Fumiaki Tanaka; Hideshi Ishii; Hiroshi Okumura; Shoji Natsugoe; Masaki Mori
STC2: a predictive marker for lymph node metastasis in esophageal squamous-cell carcinoma.
Annals of surgical oncology 2011;18(1):261-72.
2010: Kouichirou Tahara; Koshi Mimori; Hisae Iinuma; Masaaki Iwatsuki; Takehiko Yokobori; Hideshi Ishii; Hideaki Anai; Seigo Kitano; Masaki Mori
Serum matrix-metalloproteinase-1 is a bona fide prognostic marker for colorectal cancer.
Annals of surgical oncology 2010;17(12):3362-9.
2010: Masayoshi Tokuoka; Norikatsu Miyoshi; Toshiki Hitora; Koshi Mimori; Fumiaki Tanaka; Koichi Shibata; Hideshi Ishii; Mitsugu Sekimoto; Yuichiro Doki; Masaki Mori
Clinical significance of ASB9 in human colorectal cancer.
International journal of oncology 2010;37(5):1105-11.
2010: Fumiaki Tanaka; Ken Yamamoto; Sadao Suzuki; Hiroshi Inoue; Masahiko Tsurumaru; Yoshiaki Kajiyama; Hoichi Kato; Hiroyasu Igaki; Koh Furuta; Hiromasa Fujita; Toshiaki Tanaka; Yoichi Tanaka; Yoshiyuki Kawashima; Shoji Natsugoe; Tetsuro Setoyama; Shinkan Tokudome; Koshi Mimori; Naotsugu Haraguchi; Hideshi Ishii; Masaki Mori
Strong interaction between the effects of alcohol consumption and smoking on oesophageal squamous cell carcinoma among individuals with ADH1B and/or ALDH2 risk alleles.
Gut 2010;59(11):1457-64.
2010: Norikatsu Miyoshi; Hideshi Ishii; Koshi Mimori; Naohiro Nishida; Masayoshi Tokuoka; Hirofumi Akita; Mitsugu Sekimoto; Yuichiro Doki; Masaki Mori
Abnormal expression of PFDN4 in colorectal cancer: a novel marker for prognosis.
Annals of surgical oncology 2010;17(11):3030-6.
2010: Ken Konishi; Hirofumi Yamamoto; Koshi Mimori; Ichiro Takemasa; Tsunekazu Mizushima; Masataka Ikeda; Mitsugu Sekimoto; Nariaki Matsuura; Toshifumi Takao; Yuichiro Doki; Masaki Mori
Expression of C4.4A at the invasive front is a novel prognostic marker for disease recurrence of colorectal cancer.
Cancer science 2010;101(10):2269-77.
2010: Takehiko Yokobori; Koshi Mimori; Hideshi Ishii; Masaaki Iwatsuki; Fumiaki Tanaka; Yukio Kamohara; Keisuke Ieta; Yoshiaki Kita; Yuichiro Doki; Hiroyuki Kuwano; Masaki Mori
Clinical significance of stanniocalcin 2 as a prognostic marker in gastric cancer.
Annals of surgical oncology 2010;17(10):2601-7.
2010: Fumiaki Tanaka; Koshi Mimori; Kouichirou Tahara; Hiroshi Inoue; Masaki Mori
Saline replacement after local resection of the breast: a simple technique with good control and improved patient satisfaction.
Breast cancer (Tokyo, Japan) 2010;17(4):261-4.
2010: Makoto Nagahara; Koshi Mimori; Akemi Kataoka; Hideshi Ishii; Fumiaki Tanaka; Tsuyoshi Nakagawa; Takanobu Sato; Shinji Ono; Kenichi Sugihara; Masaki Mori
Correlated expression of CD47 and SIRPA in bone marrow and in peripheral blood predicts recurrence in breast cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(18):4625-35.
2010: Masaaki Iwatsuki; Koshi Mimori; Takeo Fukagawa; Hideshi Ishii; Takehiko Yokobori; Mitsuru Sasako; Hideo Baba; Masaki Mori
The clinical significance of vimentin-expressing gastric cancer cells in bone marrow.
Annals of surgical oncology 2010;17(9):2526-33.
2010: Kazuo Motoyama; Hiroshi Inoue; Koshi Mimori; Fumiaki Tanaka; Kazuyuki Kojima; Hiroyuki Uetake; Kenichi Sugihara; Masaki Mori
Clinicopathological and prognostic significance of PDCD4 and microRNA-21 in human gastric cancer.
International journal of oncology 2010;36(5):1089-95.
2010: Masaaki Iwatsuki; Koshi Mimori; Hideshi Ishii; Takehiko Yokobori; Yasushi Takatsuno; Tetsuya Sato; Hiroyuki Toh; Ichiro Onoyama; Keiichi I Nakayama; Hideo Baba; Masaki Mori
Loss of FBXW7, a cell cycle regulating gene, in colorectal cancer: clinical significance.
International journal of cancer. Journal international du cancer 2010;126(8):1828-37.
2010: Norikatsu Miyoshi; Hideshi Ishii; Koshi Mimori; Fumiaki Tanaka; Toshiki Hitora; Mitsuyoshi Tei; Mitsugu Sekimoto; Yuichiro Doki; Masaki Mori
TGM2 is a novel marker for prognosis and therapeutic target in colorectal cancer.
Annals of surgical oncology 2010;17(4):967-72.
2010: Masaaki Iwatsuki; Koshi Mimori; Tetsuya Sato; Hiroyuki Toh; Takehiko Yokobori; Fumiaki Tanaka; Koichi Ishikawa; Hideo Baba; Masaki Mori
Overexpression of SUGT1 in human colorectal cancer and its clinicopathological significance.
International journal of oncology 2010;36(3):569-75.
2010: Norikatsu Miyoshi; Hideshi Ishii; Koshi Mimori; Mitsugu Sekimoto; Yuichiro Doki; Masaki Mori
TDGF1 is a novel predictive marker for metachronous metastasis of colorectal cancer.
International journal of oncology 2010;36(3):563-8.
2010: Norikatsu Miyoshi; Hideshi Ishii; Koshi Mimori; Fumiaki Tanaka; Kennichi Nagai; Mamoru Uemura; Mitsugu Sekimoto; Yuichiro Doki; Masaki Mori
ATP11A is a novel predictive marker for metachronous metastasis of colorectal cancer.
Oncology reports 2010;23(2):505-10.
2010: Norikatsu Miyoshi; Hideshi Ishii; Koshi Mimori; Mitsugu Sekimoto; Yuichiro Doki; Masaki Mori
SCRN1 is a novel marker for prognosis in colorectal cancer.
Journal of surgical oncology 2010;101(2):156-9.
2010: Masaaki Iwatsuki; Koshi Mimori; Takehiko Yokobori; Hideshi Ishi; Toru Beppu; Shoji Nakamori; Hideo Baba; Masaki Mori
Epithelial-mesenchymal transition in cancer development and its clinical significance.
Cancer science 2010;101(2):293-9.
2010: Norikatsu Miyoshi; Hideshi Ishii; Ken-ichi Nagai; Hiromitsu Hoshino; Koshi Mimori; Fumiaki Tanaka; Hiroaki Nagano; Mitsugu Sekimoto; Yuichiro Doki; Masaki Mori
Defined factors induce reprogramming of gastrointestinal cancer cells.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(1):40-5.
2009: N Miyoshi; Hideshi Ishii; Koshi Mimori; Y Takatsuno; H Kim; H Hirose; Mitsugu Sekimoto; Yuichiro Doki; Masatomo Mori
Abnormal expression of TRIB3 in colorectal cancer: a novel marker for prognosis.
British journal of cancer 2009;101(10):1664-70.
2009: Masaaki Iwatsuki; Koshi Mimori; Takehiko Yokobori; Fumiaki Tanaka; Koichiro Tahara; Hiroshi Inoue; Hideo Baba; Masaki Mori
A platinum agent resistance gene, POLB, is a prognostic indicator in colorectal cancer.
Journal of surgical oncology 2009;100(3):261-6.
2009: Keisuke Ieta; Fumiaki Tanaka; Takehiko Yokobori; Yoshiaki Kita; Naotsugu Haraguchi; Koshi Mimori; Hiroyuki Kato; Takayuki Asao; Hiroshi Inoue; Hiroyuki Kuwano; Masaki Mori
Clinicopathological significance of stanniocalcin 2 gene expression in colorectal cancer.
International journal of cancer. Journal international du cancer 2009;125(4):926-31.
2009: Ichiro Takemasa; Hideshi Ishii; Naotsugu Haraguchi; Koshi Mimori; Fumiaki Tanaka; Hiroaki Nagano; Mitsugu Sekimoto; Yuichiro Doki; Masaki Mori
[Perspectives on current status and future directions for cancer stem cells theory in gastrointestinal cancer].
Nihon Geka Gakkai zasshi 2009;110(4):207-12.
2009: Masayoshi Tokuoka; Hideshi Ishii; Koshi Mimori; Hiroshi Inoue; Yuichiro Doki; Masaki Mori
Genetic susceptibility to gastrointestinal cancer: minireview of the genomewide studies.
Annals of surgical oncology 2009;16(7):1783-8.
2009: Shinji Matsuzaki; Fumiaki Tanaka; Koshi Mimori; Kouichirou Tahara; Hiroshi Inoue; Masaki Mori
Clinicopathologic significance of KIAA1199 overexpression in human gastric cancer.
Annals of surgical oncology 2009;16(7):2042-51.
2009: Koshi Mimori; Akemi Kataoka; Hiroshi Yamaguchi; Norikazu Masuda; Yoshimasa Kosaka; Hideshi Ishii; Shinji Ohno; Masaki Mori
Preoperative u-PAR gene expression in bone marrow indicates the potential power of recurrence in breast cancer cases.
Annals of surgical oncology 2009;16(7):2035-41.
2009: M Iwatsuki; T Fukagawa; Koshi Mimori; H Nakanishi; S Ito; H Ishii; T Yokobori; M Sasako; H Baba; Masaki Mori
Bone marrow and peripheral blood expression of ID1 in human gastric carcinoma patients is a bona fide indicator of lymph node and peritoneal metastasis.
British journal of cancer 2009;100(12):1937-42.
2009: Takehiko Yokobori; Koshi Mimori; Masaaki Iwatsuki; Hideshi Ishii; Ichiro Onoyama; Takeo Fukagawa; Hiroyuki Kuwano; Keiichi I Nakayama; Masaki Mori
p53-Altered FBXW7 expression determines poor prognosis in gastric cancer cases.
Cancer research 2009;69(9):3788-94.
2009: Kazuo Motoyama; Hiroshi Inoue; Yasushi Takatsuno; Fumiaki Tanaka; Koshi Mimori; Hiroyuki Uetake; Kenichi Sugihara; Masaki Mori
Over- and under-expressed microRNAs in human colorectal cancer.
International journal of oncology 2009;34(4):1069-75.
2009: Koshi Mimori; Masaaki Iwatsuki; Takehiko Yokobori; Masaki Mori
Important matters to identify robust markers for metastasis and recurrence in solid cancer.
Annals of surgical oncology 2009;16(4):1070-1.
2009: Y Kita; T Fukagawa; Koshi Mimori; Y Kosaka; K Ishikawa; T Aikou; S Natsugoe; M Sasako; Masatomo Mori
Expression of uPAR mRNA in peripheral blood is a favourite marker for metastasis in gastric cancer cases.
British journal of cancer 2009;100(1):153-9.
2009: Y Kita; Koshi Mimori; Fumiaki Tanaka; T Matsumoto; N Haraguchi; K Ishikawa; S Matsuzaki; Y Fukuyoshi; Hiroshi Inoue; S Natsugoe; T Aikou; Masatomo Mori
Clinical significance of LAMB3 and COL7A1 mRNA in esophageal squamous cell carcinoma.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2009;35(1):52-8.
2008: Koshi Mimori; Hideshi Ishii; Hiroshi Inoue; Graham F Barnard; Masaki Mori
Identification of the expression profile of apoptotic esophageal cancer cells by adenoviral-fragile histidine triad treatment.
Journal of gastroenterology and hepatology 2008;23 Suppl 2():S205-9.
2008: Katsuya Sakashita; Fumiaki Tanaka; Xiang Zhang; Koshi Mimori; Yukio Kamohara; Hiroshi Inoue; Tetsuji Sawada; Kosei Hirakawa; Masaki Mori
Clinical significance of ApoE expression in human gastric cancer.
Oncology reports 2008;20(6):1313-9.
2008: Katsuya Sakashita; Koshi Mimori; Fumiaki Tanaka; Kouichirou Tahara; Hiroshi Inoue; Tetsuji Sawada; Masaichi Ohira; Kosei Hirakawa; Masaki Mori
Clinical significance of low expression of Prostasin mRNA in human gastric cancer.
Journal of surgical oncology 2008;98(7):559-64.
2008: Hideshi Ishii; Masaaki Iwatsuki; Keisuke Ieta; Daisuke Ohta; Naotsugu Haraguchi; Koshi Mimori; Masaki Mori
Cancer stem cells and chemoradiation resistance.
Cancer science 2008;99(10):1871-7.
2008: Koshi Mimori; Takeo Fukagawa; Yoshimasa Kosaka; Kenji Ishikawa; Masaaki Iwatsuki; Takehiko Yokobori; Shigeo Hirasaki; Yasushi Takatsuno; Hiroyuki Sakashita; Hideshi Ishii; Mitsuru Sasako; Masaki Mori
A large-scale study of MT1-MMP as a marker for isolated tumor cells in peripheral blood and bone marrow in gastric cancer cases.
Annals of surgical oncology 2008;15(10):2934-42.
2008: Keiji Yoshinaga; Koshi Mimori; Hiroshi Inoue; Yukio Kamohara; Keishi Yamashita; Fumiaki Tanaka; Masaki Mori
Activin A enhances MMP-7 activity via the transcription factor AP-1 in an esophageal squamous cell carcinoma cell line.
International journal of oncology 2008;33(3):453-9.
2008: Katsuya Sakashita; Koshi Mimori; Fumiaki Tanaka; Yukio Kamohara; Hiroshi Inoue; Tetsuji Sawada; Kosei Hirakawa; Masaki Mori
Prognostic relevance of Tensin4 expression in human gastric cancer.
Annals of surgical oncology 2008;15(9):2606-13.
2008: Yukio Kamohara; Naotsugu Haraguchi; Koshi Mimori; Fumiaki Tanaka; Hiroshi Inoue; Masaki Mori; Takashi Kanematsu
The search for cancer stem cells in hepatocellular carcinoma.
Surgery 2008;144(2):119-24.
2008: Yoshito Nakamura; Fumiaki Tanaka; Yasuji Yoshikawa; Koshi Mimori; Hiroshi Inoue; Katsuhiko Yanaga; Masaki Mori
PDGF-BB is a novel prognostic factor in colorectal cancer.
Annals of surgical oncology 2008;15(8):2129-36.
2008: Katsuya Sakashita; Koshi Mimori; Fumiaki Tanaka; Yukio Kamohara; Hiroshi Inoue; Tetsuji Sawada; Kosei Hirakawa; Masaki Mori
Clinical significance of loss of Fhl1 expression in human gastric cancer.
Annals of surgical oncology 2008;15(8):2293-300.
2008: K Ishikawa; Y Kamohara; F Tanaka; N Haraguchi; Koshi Mimori; Hiroshi Inoue; Masaki Mori
Mitotic centromere-associated kinesin is a novel marker for prognosis and lymph node metastasis in colorectal cancer.
British journal of cancer 2008;98(11):1824-9.
2008: Xiang Zhang; Hisashi Nagahara; Koshi Mimori; Hiroshi Inoue; Tetsuji Sawada; Masaichi Ohira; Kosei Hirakawa; Masaki Mori
Mutations of epidermal growth factor receptor in colon cancer indicate susceptibility or resistance to gefitinib.
Oncology reports 2008;19(6):1541-4.
2008: Kazuo Motoyama; Fumiaki Tanaka; Yoshimasa Kosaka; Koshi Mimori; Hiroyuki Uetake; Hiroshi Inoue; Kenichi Sugihara; Masaki Mori
Clinical significance of BMP7 in human colorectal cancer.
Annals of surgical oncology 2008;15(5):1530-7.
2008: Takeshi Yokoe; Fumiaki Tanaka; Koshi Mimori; Hiroshi Inoue; Takahiro Ohmachi; Masato Kusunoki; Masaki Mori
Efficient identification of a novel cancer/testis antigen for immunotherapy using three-step microarray analysis.
Cancer research 2008;68(4):1074-82.
2008: Keisuke Ieta; Fumiaki Tanaka; Naotsugu Haraguchi; Yoshiaki Kita; Hiroyuki Sakashita; Koshi Mimori; Toshifumi Matsumoto; Hiroshi Inoue; Hiroyuki Kuwano; Masaki Mori
Biological and genetic characteristics of tumor-initiating cells in colon cancer.
Annals of surgical oncology 2008;15(2):638-48.
2008: M Ohta; Koshi Mimori; Y Fukuyoshi; Y Kita; K Motoyama; K Yamashita; H Ishii; Hiroshi Inoue; Masatomo Mori
Clinical significance of the reduced expression of G protein gamma 7 (GNG7) in oesophageal cancer.
British journal of cancer 2008;98(2):410-7.
2008: Keiji Yoshinaga; Keishi Yamashita; Koshi Mimori; Fumiaki Tanaka; Hiroshi Inoue; Masaki Mori
Activin a causes cancer cell aggressiveness in esophageal squamous cell carcinoma cells.
Annals of surgical oncology 2008;15(1):96-103.
2007: Takeshi Yokoe; Takahiro Ohmachi; Hiroshi Inoue; Koshi Mimori; Fumiaki Tanaka; Masato Kusunoki; Masaki Mori
Clinical significance of growth differentiation factor 11 in colorectal cancer.
International journal of oncology 2007;31(5):1097-101.
2007: Yoshimasa Kosaka; Hiroshi Inoue; Takahiro Ohmachi; Takeshi Yokoe; Toshifumi Matsumoto; Koshi Mimori; Fumiaki Tanaka; Masahiko Watanabe; Masaki Mori
Tripartite motif-containing 29 (TRIM29) is a novel marker for lymph node metastasis in gastric cancer.
Annals of surgical oncology 2007;14(9):2543-9.
2007: Yoshito Nakamura; Fumiaki Tanaka; Naotsugu Haraguchi; Koshi Mimori; T Matsumoto; Hiroshi Inoue; Katsuhiko Yanaga; Masaki Mori
Clinicopathological and biological significance of mitotic centromere-associated kinesin overexpression in human gastric cancer.
British journal of cancer 2007;97(4):543-9.
2007: Yoshimasa Kosaka; Koshi Mimori; Fumiaki Tanaka; Hiroshi Inoue; Masahiko Watanabe; Masaki Mori
Clinical significance of the loss of MATS1 mRNA expression in colorectal cancer.
International journal of oncology 2007;31(2):333-8.
2007: Keisuke Ieta; Eiki Ojima; Fumiaki Tanaka; Yoshito Nakamura; Naotsugu Haraguchi; Koshi Mimori; Hiroshi Inoue; Hiroyuki Kuwano; Masaki Mori
Identification of overexpressed genes in hepatocellular carcinoma, with special reference to ubiquitin-conjugating enzyme E2C gene expression.
International journal of cancer. Journal international du cancer 2007;121(1):33-8.
2007: Yoshimasa Kosaka; Koshi Mimori; Masaki Mori; Noriyuki Moriyama; Masahiko Watanabe
[Breast neoplasms: micrometastasis].
Nihon rinsho. Japanese journal of clinical medicine 2007;65 Suppl 6():47-53.
2007: Y Kosaka; Koshi Mimori; T Fukagawa; K Ishikawa; T Etoh; H Katai; T Sano; M Watanabe; M Sasako; Masatomo Mori
Identification of the high-risk group for metastasis of gastric cancer cases by vascular endothelial growth factor receptor-1 overexpression in peripheral blood.
British journal of cancer 2007;96(11):1723-8.
2007: Koshi Mimori; Kohjiro Nishida; Yoshito Nakamura; Keisuke Ieta; Yasuji Yoshikawa; Atsushi Sasaki; Hideshi Ishii; Miguel A Alonso; Masaki Mori
Loss of MAL expression in precancerous lesions of the esophagus.
Annals of surgical oncology 2007;14(5):1670-7.
2007: Shigeo Hirasaki; Tsuyoshi Noguchi; Koshi Mimori; Junko Onuki; Keiko Morita; Hiroshi Inoue; Kenichi Sugihara; Masaki Mori; Takashi Hirano
BAC clones related to prognosis in patients with esophageal squamous carcinoma: an array comparative genomic hybridization study.
The oncologist 2007;12(4):406-17.
2007: Yoshito Nakamura; Fumiaki Tanaka; Hisashi Nagahara; Keisuke Ieta; Naotsugu Haraguchi; Koshi Mimori; Atsushi Sasaki; Hiroshi Inoue; Katsuhiko Yanaga; Masaki Mori
Opa interacting protein 5 (OIP5) is a novel cancer-testis specific gene in gastric cancer.
Annals of surgical oncology 2007;14(2):885-92.
2007: Tomoya Sudo; Koshi Mimori; Hisashi Nagahara; Tohru Utsunomiya; H Fujita; Y Tanaka; K Shirouzu; Hiroshi Inoue; Masatomo Mori
Identification of EGFR mutations in esophageal cancer.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2007;33(1):44-8.
2007: Fumiaki Tanaka; Hideto Sonoda; Masahiro Okamoto; Koshi Mimori; Tohru Utsunomiya; Hiroshi Inoue; Taizo Hanai; Masaki Mori
TIMP-3 and Phosphatidylinositol 3-kinase genes were found to be related to the progression of colon cancer in a comparison of pneumoperitoneum and laparotomy in a murine model.
Surgery today 2007;37(3):220-5.
2006: Takahiro Ohmachi; Hiroshi Inoue; Koshi Mimori; Fumiaki Tanaka; Atsushi Sasaki; Tatsuo Kanda; Hiroshi Fujii; Katsuhiko Yanaga; Masaki Mori
Fatty acid binding protein 6 is overexpressed in colorectal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(17):5090-5.
2006: Takahiro Ohmachi; Fumiaki Tanaka; Koshi Mimori; Hiroshi Inoue; Katsuhiko Yanaga; Masaki Mori
Clinical significance of TROP2 expression in colorectal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(10):3057-63.
2006: Takaaki Masuda; Koshi Mimori; Masaki Mori
[Occult micrometastasis].
Nihon rinsho. Japanese journal of clinical medicine 2006;64(3):442-9.
2006: Koshi Mimori; Hideshi Ishii; Hisashi Nagahara; Tomoya Sudo; Keishi Yamashita; Hiroshi Inoue; Graham F Barnard; Masaki Mori
FHIT is up-regulated by inflammatory stimuli and inhibits prostaglandin E2-mediated cancer progression.
Cancer research 2006;66(5):2683-90.
2006: Kazuhiko Ogawa; Tohru Utsunomiya; Koshi Mimori; Fumiaki Tanaka; Naotsugu Haraguchi; Hiroshi Inoue; Sadayuki Murayama; Masaki Mori
Differential gene expression profiles of radioresistant pancreatic cancer cell lines established by fractionated irradiation.
International journal of oncology 2006;28(3):705-13.
2006: Naotsugu Haraguchi; Tohru Utsunomiya; Hiroshi Inoue; Fumiaki Tanaka; Koshi Mimori; Graham F Barnard; Masaki Mori
Characterization of a side population of cancer cells from human gastrointestinal system.
Stem cells (Dayton, Ohio) 2006;24(3):506-13.
2006: Naotsugu Haraguchi; Hiroshi Inoue; Fumiaki Tanaka; Koshi Mimori; Tohru Utsunomiya; Atsushi Sasaki; Masaki Mori
Cancer stem cells in human gastrointestinal cancers.
Human cell 2006;19(1):24-9.
2006: Koshi Mimori; Hisashi Nagahara; Tomoya Sudo; Hideshi Ishii; Keishi Yamashita; Graham F Barnard; Masaki Mori
The epidermal growth factor receptor gene sequence is highly conserved in primary gastric cancers.
Journal of surgical oncology 2006;93(1):44-6.
2005: Hisashi Nagahara; Koshi Mimori; Tohru Utsunomiya; Graham F Barnard; Masaichi Ohira; Kosei Hirakawa; Masaki Mori
Clinicopathologic and biological significance of kallikrein 6 overexpression in human gastric cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(19 Pt 1):6800-6.
2005: Koshi Mimori; Hisashi Nagahara; Graham F Barnard; Masaki Mori
Epidermal growth factor receptor gene is highly conserved in pancreatic cancer cells.
Pancreas 2005;31(3):299.
2005: Tohru Utsunomiya; Kazuhiko Ogawa; Keiji Yoshinaga; Mitsuhiko Ohta; Keishi Yamashita; Koshi Mimori; Hiroshi Inoue; Takahiro Ezaki; Yasuji Yoshikawa; Masaki Mori
Clinicopathologic and prognostic values of apolipoprotein D alterations in hepatocellular carcinoma.
International journal of cancer. Journal international du cancer 2005;116(1):105-9.
2005: Kazuhiko Ogawa; Tohru Utsunomiya; Koshi Mimori; Keishi Yamashita; Masahiro Okamoto; Fumiaki Tanaka; Hiroshi Inoue; Yoichi Ikeda; Motonori Saku; Sadayuki Murayama; Masaki Mori
Genomic screens for genes upregulated by demethylation in colorectal cancer: possible usefulness for clinical application.
International journal of oncology 2005;27(2):417-26.
2005: Tomoya Sudo; Tohru Utsunomiya; Koshi Mimori; Hisashi Nagahara; K Ogawa; Hiroshi Inoue; S Wakiyama; H Fujita; K Shirouzu; Masatomo Mori
Clinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma.
British journal of cancer 2005;92(9):1754-8.
2005: Koshi Mimori; K Ogawa; M Okamoto; Tomoya Sudo; Hiroshi Inoue; Masatomo Mori
Clinical significance of enhancer of zeste homolog 2 expression in colorectal cancer cases.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2005;31(4):376-80.
2005: Kazuhiko Ogawa; Tohru Utsunomiya; Koshi Mimori; Fumiaki Tanaka; Hiroshi Inoue; Hisashi Nagahara; Sadayuki Murayama; Masaki Mori
Clinical significance of human kallikrein gene 6 messenger RNA expression in colorectal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(8):2889-93.
2005: Taka-Aki Masuda; Akemi Kataoka; Shinji Ohno; Shigeru Murakami; Koshi Mimori; Tohru Utsunomiya; Hiroshi Inoue; Shinichi Tsutsui; Junko Kinoshita; Norikazu Masuda; Noriyuki Moriyama; Masaki Mori
Detection of occult cancer cells in peripheral blood and bone marrow by quantitative RT-PCR assay for cytokeratin-7 in breast cancer patients.
International journal of oncology 2005;26(3):721-30.
2005: Hisashi Nagahara; Koshi Mimori; Mitsuhiko Ohta; Tohru Utsunomiya; Hiroshi Inoue; Graham F Barnard; Masaichi Ohira; Kosei Hirakawa; Masaki Mori
Somatic mutations of epidermal growth factor receptor in colorectal carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(4):1368-71.
2004: Koshi Mimori; Keishi Yamashita; Mitsuhiko Ohta; Keiji Yoshinaga; Kenji Ishikawa; Hideshi Ishii; Tohru Utsunomiya; Graham F Barnard; Hiroshi Inoue; Masaki Mori
Coexpression of matrix metalloproteinase-7 (MMP-7) and epidermal growth factor (EGF) receptor in colorectal cancer: an EGF receptor tyrosine kinase inhibitor is effective against MMP-7-expressing cancer cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(24):8243-9.
2004: Tohru Utsunomiya; Hiroshi Inoue; Fumiaki Tanaka; Hiroshi Yamaguchi; Mitsuhiko Ohta; Masahiro Okamoto; Koshi Mimori; Masaki Mori
Expression of cancer-testis antigen (CTA) genes in intrahepatic cholangiocarcinoma.
Annals of surgical oncology 2004;11(10):934-40.
2004: Keiji Yoshinaga; Hiroshi Inoue; Tohru Utsunomiya; Hideto Sonoda; Takaaki Masuda; Koshi Mimori; Yoichi Tanaka; Masaki Mori
N-cadherin is regulated by activin A and associated with tumor aggressiveness in esophageal carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(17):5702-7.
2004: Tohru Utsunomiya; Masahiro Okamoto; Masaji Hashimoto; Keiji Yoshinaga; Takeshi Shiraishi; Fumiaki Tanaka; Koshi Mimori; Hiroshi Inoue; Goro Watanabe; Graham F Barnard; Masaki Mori
A gene-expression signature can quantify the degree of hepatic fibrosis in the rat.
Journal of hepatology 2004;41(3):399-406.
2004: Naotsugu Haraguchi; Hiroshi Inoue; Koshi Mimori; Fumiaki Tanaka; Tohru Utsunomiya; Kouji Yoshikawa; Masaki Mori
Analysis of gastric cancer with cDNA microarray.
Cancer chemotherapy and pharmacology 2004;54 Suppl 1():S21-4.
2004: K Ogawa; T Utsunomiya; Koshi Mimori; Y Tanaka; F Tanaka; H Inoue; S Murayama; Masaki Mori
Clinical significance of elongation factor-1 delta mRNA expression in oesophageal carcinoma.
British journal of cancer 2004;91(2):282-6.
2004: Koshi Mimori; Hiroaki Ueo; Tamotsu Kuroki; Takeshi Shiraishi; Shenoa Creer; Scott Taylor; Hideshi Ishii; Masaki Mori
Prediction of 5'-deoxy-5-fluorouridine sensitivity in colorectal cancer cases by thymidine phosphorylase activity and preliminary identification of susceptibility related genes.
Oncology reports 2004;12(1):19-23.
2004: Keishi Yamashita; Yoichi Tanaka; Koshi Mimori; Hiroshi Inoue; Masaki Mori
Differential expression of MMP and uPA systems and prognostic relevance of their expression in esophageal squamous cell carcinoma.
International journal of cancer. Journal international du cancer 2004;110(2):201-7.
2004: Koshi Mimori; Y Tanaka; K Yoshinaga; T Masuda; K Yamashita; M Okamoto; H Inoue; Masatomo Mori
Clinical significance of the overexpression of the candidate oncogene CYP24 in esophageal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(2):236-41.
2003: Keiji Yoshinaga; Hiroshi Inoue; Fumiaki Tanaka; Koshi Mimori; Tohru Utsunomiya; Masaki Mori
Platelet-derived endothelial cell growth factor mediates Rho-associated coiled-coil domain kinase messenger RNA expression and promotes cell motility.
Annals of surgical oncology 2003;10(5):582-7.
2003: Koshi Mimori; Takeshi Shiraishi; Kohjiro Mashino; Hideto Sonoda; Keishi Yamashita; Keiji Yoshinaga; Takaaki Masuda; Tohru Utsunomiya; Miguel A Alonso; Hiroshi Inoue; Masaki Mori
MAL gene expression in esophageal cancer suppresses motility, invasion and tumorigenicity and enhances apoptosis through the Fas pathway.
Oncogene 2003;22(22):3463-71.
2003: Koshi Mimori; Hiroshi Inoue; Hideshi Ishii; Masaki Mori
INI-1, a partner gene of ALL-1, is highly conserved in human acute leukemia.
Oncology reports 2003;10(3):551-3.
2003: Koshi Mimori; Hiroshi Inoue; Takeshi Shiraishi; Ayumi Matsuyama; Ken-ichi Mafune; Yoichi Tanaka; Masaki Mori
Microsatellite instability is often observed in esophageal carcinoma patients with allelic loss in the FHIT/FRA3B locus.
Oncology 2003;64(3):275-9.
2003: Keiji Yoshinaga; Koshi Mimori; Keishi Yamashita; Tohru Utsunomiya; Hiroshi Inoue; Masaki Mori
Clinical significance of the expression of activin A in esophageal carcinoma.
International journal of oncology 2003;22(1):75-80.
2002: Hiroshi Inoue; Ayumi Matsuyama; Koshi Mimori; Hiroaki Ueo; Masaki Mori
Prognostic score of gastric cancer determined by cDNA microarray.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(11):3475-9.
2002: Koshi Mimori; Hiroshi Inoue; Takeshi Shiraishi; Hiroaki Ueo; Ken-ichi Mafune; Yoichi Tanaka; Masaki Mori
A single-nucleotide polymorphism of SMARCB1 in human breast cancers.
Genomics 2002;80(3):254-8.
2002: Koshi Mimori; Masaki Mori
[Recent advances in the diagnosis and treatment of colorectal cancers].
Nihon Geka Gakkai zasshi 2002;103(6):468-71.
2002: Koshi Mimori; Ayumi Matsuyama; Keiji Yoshinaga; Keishi Yamashita; Takaaki Masuda; Hiroshi Inoue; Hiroaki Ueo; Masaki Mori
Localization of thymidine phosphorylase expression in colorectal carcinoma tissues by in situ RT-PCR assay.
Oncology 2002;62(4):327-32.
2001: Masatomo Mori; Koshi Mimori; T Masuda; K Yoshinaga; Keishi Yamashita; Ayumi Matsuyama; Hiroshi Inoue
Absence of Msh2 protein expression is associated with alteration in the FHIT locus and Fhit protein expression in colorectal carcinoma.
Cancer research 2001;61(20):7379-82.
2001: Akemi Kataoka; Noriaki Sadanaga; Koshi Mimori; Hiroaki Ueo; Graham F Barnard; Keizo Sugimachi; D Auclair; Lan Bo Chen; Masatomo Mori
Overexpression of HRad17 mRNA in human breast cancer: correlation with lymph node metastasis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(9):2815-20.
2001: Hiroshi Inoue; Koshi Mimori; T Utsunomiya; Noriaki Sadanaga; Graham F Barnard; Hiroaki Ueo; Masatomo Mori
Heparanase expression in clinical digestive malignancies.
Oncology reports 2001;8(3):539-42.
2001: Koshi Mimori; Hiroaki Ueo; Chiaki Shirasaka; Masatomo Mori
Clinical significance of MT1-MMP mRNA expression in breast cancer.
Oncology reports 2001;8(2):401-3.
2001: Yoshiaki Kinoshita; Sadafumi Tamiya; Yoshinao Oda; Koshi Mimori; H Inoue; Shigeru Ohta; T Tajiri; Sachiyo Suita; Masazumi Tsuneyoshi
Establishment and characterization of malignant rhabdoid tumor of the kidney.
Oncology reports 2001;8(1):43-8.
2001: Koshi Mimori; Hiroshi Inoue; H Alder; Hiroaki Ueo; Y Tanaka; Masatomo Mori
Mutation analysis of hBUB1, human mitotic checkpoint gene in multiple carcinomas.
Oncology reports 2001;8(1):39-42.
2000: Masatomo Mori; Koshi Mimori; Noriaki Sadanaga; Hiroshi Inoue; Y Tanaka; Ken-ichi Mafune; Hiroaki Ueo; Graham F Barnard
Prognostic impact of tissue inhibitor of matrix metalloproteinase-1 in esophageal carcinoma.
International journal of cancer. Journal international du cancer 2000;88(4):575-8.
2000: Koshi Mimori; Masatomo Mori; Y Adachi; M A Antonyak; M Kinoshita; H Kusaka; K Sugimachi
Analysis of the genetic alterations in a case of juvenile multiple colon carcinoma with hypogammaglobulinemia.
Annals of surgical oncology 2000;7(9):692-5.
2000: Hiroshi Inoue; Koshi Mimori; T Shiraishi; Akemi Kataoka; Noriaki Sadanaga; Hiroaki Ueo; Graham F Barnard; Masatomo Mori
Expression of tissue inhibitor of matrix metalloproteinase-1 in human breast carcinoma.
Oncology reports 2000;7(4):871-4.
2000: Masatomo Mori; Koshi Mimori; Takeshi Shiraishi; H Alder; Hiroshi Inoue; Yoichi Tanaka; K Sugimachi; K Huebner; C M Croce
Altered expression of Fhit in carcinoma and precarcinomatous lesions of the esophagus.
Cancer research 2000;60(5):1177-82.
1999: M Yamagata; Masatomo Mori; Koshi Mimori; Ken-ichi Mafune; Y Tanaka; Hiroaki Ueo; Takashi Akiyoshi
Expression of pyrimidine nucleoside phosphorylase mRNA plays an important role in the prognosis of patients with oesophageal cancer.
British journal of cancer 1999;79(3-4):565-9.
1999: Koshi Mimori; Hiroaki Ueo; Chiaki Shirasaka; T Shiraishi; M Yamagata; M Haraguchi; Masatomo Mori
Up-regulated pyrimidine nucleoside phosphorylase in breast carcinoma correlates with lymph node metastasis.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(1):111-3.
1998: Masatomo Mori; Koshi Mimori; T Shiraishi; M Haraguchi; Hiroaki Ueo; Graham F Barnard; Takashi Akiyoshi
Motility related protein 1 (MRP1/CD9) expression in colon cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(6):1507-10.
1998: Koshi Mimori; Masatomo Mori; T Shiraishi; Shinji Tanaka; M Haraguchi; Hiroaki Ueo; Chiaki Shirasaka; Takashi Akiyoshi
Expression of ornithine decarboxylase mRNA and c-myc mRNA in breast tumours.
International journal of oncology 1998;12(3):597-601.
1997: J Li; Y Yang; T Fujie; F Tanaka; Koshi Mimori; M Haraguchi; Hiroaki Ueo; Masatomo Mori; Takashi Akiyoshi
Expression of the MAGE gene family in human gastric carcinoma.
Anticancer research 1997;17(5A):3559-63.
1997: Koshi Mimori; Masatomo Mori; T Shiraishi; T Fujie; K Baba; H Kusumoto; M Haraguchi; Hiroaki Ueo; Takashi Akiyoshi
Analysis of ornithine decarboxylase messenger ribonucleic acid expression in colorectal carcinoma.
Diseases of the colon and rectum 1997;40(9):1095-100.
1997: Masatomo Mori; Koshi Mimori; T Shiraishi; T Fujie; K Baba; H Kusumoto; M Haraguchi; Hiroaki Ueo; Takashi Akiyoshi
Analysis of MT1-MMP and MMP2 expression in human gastric cancers.
International journal of cancer. Journal international du cancer 1997;74(3):316-21.
1997: Koshi Mimori; Masatomo Mori; T Shiraishi; T Fujie; K Baba; M Haraguchi; R Abe; Hiroaki Ueo; Takashi Akiyoshi
Clinical significance of tissue inhibitor of metalloproteinase expression in gastric carcinoma.
British journal of cancer 1997;76(4):531-6.
1996: Masatomo Mori; Koshi Mimori; Hiroaki Ueo; N Karimine; Graham F Barnard; K Sugimachi; Takashi Akiyoshi
Molecular detection of circulating solid carcinoma cells in the peripheral blood: the concept of early systemic disease.
International journal of cancer. Journal international du cancer 1996;68(6):739-43.
1996: Masatomo Mori; H Inoue; T Shiraishi; Koshi Mimori; Kenji Shibuta; H Nakashima; Ken-ichi Mafune; Y Tanaka; Hiroaki Ueo; Graham F Barnard; K Sugimachi; Takashi Akiyoshi
Relaxation of insulin-like growth factor 2 gene imprinting in esophageal cancer.
International journal of cancer. Journal international du cancer 1996;68(4):441-6.
1996: Shuhei Imayama; Masatomo Mori; Hiroaki Ueo; S Nanbara; Y Adachi; Koshi Mimori; Y Shimozono; Y Hori; K Sugimachi
Presence of elevated carcinoembryonic antigen on absorbent disks applied to nipple area of breast carcinoma patients.
Cancer 1996;78(6):1229-34.
1996: Masatomo Mori; H Inoue; Koshi Mimori; Kenji Shibuta; K Baba; H Nakashima; M Haraguchi; K Tsuji; Hiroaki Ueo; Graham F Barnard; Takashi Akiyoshi
Expression of MAGE genes in human colorectal carcinoma.
Annals of surgery 1996;224(2):183-8.
1996: Masatomo Mori; Koshi Mimori; S Tanaka; K Baba; H Kusumoto; M Haraguchi; Takashi Akiyoshi
[Prognostic factors of colon cancer from a molecular biology standpoint].
Gan to kagaku ryoho. Cancer & chemotherapy 1996;23(8):982-9.
1996: Masatomo Mori; H Nakashima; Koshi Mimori; Y Tanaka; Ken-ichi Mafune; H Ueo; K Sugimachi; Takashi Akiyoshi
[Clinical significance of genetic instability in gastrointestinal cancers].
Nihon rinsho. Japanese journal of clinical medicine 1996;54(4):1025-30.
1996: Koshi Mimori; Masatomo Mori; K Morinaga; K Sugimachi
A new approach for acute embolus occlusion of the superior mesenteric artery.
Surgery today 1996;26(11):949-51.
1996: Koshi Mimori; Masatomo Mori; H Inoue; Hiroaki Ueo; Ken-ichi Mafune; Takashi Akiyoshi; K Sugimachi
Elongation factor 1 gamma mRNA expression in oesophageal carcinoma.
Gut 1996;38(1):66-70.
1995: H Inoue; M Mori; J Li; Koshi Mimori; M Honda; H Nakashima; Ken-ichi Mafune; Y Tanaka; T Akiyoshi
Human esophageal carcinomas frequently express the tumor-rejection antigens of MAGE genes.
International journal of cancer. Journal international du cancer 1995;63(4):523-6.
1995: H Inoue; M Mori; M Honda; J Li; Kenji Shibuta; Koshi Mimori; Hiroaki Ueo; Takashi Akiyoshi
The expression of tumor-rejection antigen "MAGE" genes in human gastric carcinoma.
Gastroenterology 1995;109(5):1522-5.
1995: H Nakashima; Masatomo Mori; Koshi Mimori; H Inoue; Kenji Shibuta; K Baba; Ken-ichi Mafune; Takashi Akiyoshi
Microsatellite instability in Japanese esophageal carcinoma.
International journal of cancer. Journal international du cancer 1995;64(4):286-9.
1995: Tadahiro Nozoe; Hiroyuki Kuwano; M Watanabe; M Yasuda; Noriaki Sadanaga; Koshi Mimori; K Sugimachi
The long-term results of pre-operative hyperthermo-chemo-radiotherapy for oesophageal carcinoma--a comparison with preoperative radiation therapy alone.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1995;21(4):374-8.
1995: Masatomo Mori; Koshi Mimori; T Kamakura; Y Adachi; Y Ikeda; K Sugimachi
Chromogranin positive cells in colorectal carcinoma and transitional mucosa.
Journal of clinical pathology 1995;48(8):754-8.
1995: Masatomo Mori; Koshi Mimori; H Inoue; Graham F Barnard; K Tsuji; S Nanbara; Hiroaki Ueo; Takashi Akiyoshi
Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction.
Cancer research 1995;55(15):3417-20.
1995: Koshi Mimori; Masatomo Mori; H Kuwano; K Sugimachi
Hyperthermochemoradiotherapy is effective for small cell carcinoma of the esophagus.
Journal of surgical oncology 1995;59(1):63-6.
1995: Masatomo Mori; Graham F Barnard; Koshi Mimori; Hiroaki Ueo; Takashi Akiyoshi; K Sugimachi
Overexpression of matrix metalloproteinase-7 mRNA in human colon carcinomas.
Cancer 1995;75(6 Suppl):1516-9.
1995: Koshi Mimori; Masatomo Mori; S Tanaka; Takashi Akiyoshi; K Sugimachi
The overexpression of elongation factor 1 gamma mRNA in gastric carcinoma.
Cancer 1995;75(6 Suppl):1446-9.
1995: Koshi Mimori; Masatomo Mori; H Baba; Y Maehara; K Sugimachi
Complete response of transverse colon carcinoma to S1, a new chemotherapy agent: report of a case.
Surgery today 1995;25(8):741-4.
1994: Masatomo Mori; Koshi Mimori; Noriaki Sadanaga; M Watanabe; Hiroyuki Kuwano; K Sugimachi
Polypoid carcinoma of the esophagus.
Japanese journal of cancer research : Gann 1994;85(11):1131-6.
1994: Masatomo Mori; M Watanabe; S Tanaka; Koshi Mimori; H Kuwano; K Sugimachi
Epstein-Barr virus-associated carcinomas of the esophagus and stomach.
Archives of pathology & laboratory medicine 1994;118(10):998-1001.
1994: Hiroyuki Kuwano; M Watanabe; Noriaki Sadanaga; T Kamakura; Tadahiro Nozoe; M Yasuda; Koshi Mimori; Masatomo Mori; K Sugimachi
Univariate and multivariate analyses of the prognostic significance of discontinuous intramural metastasis in patients with esophageal cancer.
Journal of surgical oncology 1994;57(1):17-21.
1994: Koshi Mimori; Masatomo Mori; T Matsushima; Y Adachi; Hiroyuki Kuwano; K Sugimachi
[DNA heterogeneity and its significance in colon carcinoma].
Gan to kagaku ryoho. Cancer & chemotherapy 1994;21 Suppl 1():37-40.